Media Thread, page-6898

Hi TBull and WellsE

I can't imagine that Amgen were unaware, in any way, that Imugene and themselves were partnering in this way.

The only thing that I found strange, as did WellsEicke and others, is that the 3rd partnership remained a mystery for so long.
SH knew for a while that there was a third paper coming but nothing further was revealed.
Not being privy to IMU board discussions I can only really guess as to why.
Saying that, I can't imagine any reason that Team IMU would need/desire to keep the partnership 'under wraps' for an extended period so it leads me to suspect that the request to hold off (or embargo) must have come from Amgen themselves. It could have been as simple as having to gain some level of sign-off from their stakeholders or existing partners. I just don't know.

What I 'hope' I know is that the range of IMU treatments will be one of the first 'go-to' treatments for cancer combos, across the board.
I believe we are already witnessing this in a big way and this can only be a very BIG thing for IMU.